Inogen | INGN - Pre Tax Profit


Inogen reported $-6.06M in Pre-Tax Profit for its fiscal quarter ending in September of 2024.





Pre Tax Profit Change Date
Abbott USD 2.36B 178M Dec/2025
AngioDynamics USD -4M 1.74M Feb/2025
AtriCure USD -86K 5.84M Sep/2025
Baxter International USD 121M 12M Sep/2025
Becton, Dickinson and Co. USD 510M 193M Sep/2025
Boston Scientific USD 938M 3M Sep/2025
Chart Industries USD 95.4M 23.5M Jun/2025
Cooper Companies USD 254.2M 27.6M Jun/2025
Dexcom USD 300M 58.9M Sep/2025
Edwards Lifesciences USD 348.4M 51.8M Sep/2025
Globus Medical USD 188.17M 84.5M Jun/2025
Inogen USD -6.06M 467K Sep/2024
Insulet USD 122.8M 94.4M Sep/2025
Masimo USD 74.9M 19.5M Sep/2025
Medtronic USD 2.1B 224M Sep/2025
Orthofix International USD -123.88M 97.24M Dec/2024
Philips EUR 275M 62M Sep/2025
ResMed USD 482.38M 2.51M Sep/2025
Steris USD 324.4M 92.5M Sep/2025
Stryker USD 1.03B 13M Sep/2025
Tandem Diabetes Care USD -57.72M 64.37M Jun/2025
Teleflex USD -438.58M 573.82M Sep/2025
X T L Biopharmaceuticals USD -385K 168K Dec/2024
Zimmer Biomet Holdings USD 418.7M 194.1M Sep/2025